Skyrocketing drug prices are hitting dermatology hard. Why are Americans paying more than other countries? Are Pharmacy Benefit Managers (PBMs) or pharmaceutical companies to blame? Join Derms on Drugs as our experts pull back the curtain on the broken system driving costs. Get insider insights, practical takeaways, and our trademark banter to navigate this mess as a clinician.Derms on Drugs is a production of Scholarsinmedicine.com1. Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US2. Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis3. AI Description and Answers About How Drug Pricing WorksScholarsinmedicine.com
--------
1:06:40
Man vs Machine - Are computers and AI going to replace dermatologists?
Join Derms on Drugs for a riveting dive into artificial intelligence and automated skin cancer detection. World-renowned expert Dr. Laura Ferris, with 20 years in the field, breaks down cutting-edge research and predicts the future of dermatology. Will AI "terminate" dermatologists or empower us to focus on complex cases and patient care? Expect fresh insights, practical takeaways, and lively banter that’ll make you a smarter clinician. Don’t miss this chance to stay ahead in the AI revolution!Derms on Drugs is produced by Scholars In MedicineFor Resources links visit: Scholars In Medicine1. Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?2. 3D Total-Body Photography in Patients at High Risk for Melanoma3. Promises and Pitfalls of 3D Total-Body Photography for Melanoma Early Detection4. Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance5. Standard Dermatoscope Images vs an Autonomous Total Body Photography and Dermoscopic Imaging Device
--------
56:16
Melanoma, Pre-Menstrual Rashes, Dermatomyositis and more
Tune in to Derms on Drugs for a the most fun you can have while diving into the hottest dermatology topics! This week, we unpack cutting-edge insights from the latest literature to make you a sharper clinician. Explore adjuvant therapy for Stage 3A melanoma, the pitfalls of dermatomyositis misdiagnosis, and a surprising finding: is hydroxychloroquine outperforming NBUVB for vitiligo? Plus, discover new skin-gut-immune connections, tackle cancer immunotherapy-induced pemphigoid, and learn how to manage premenstrual rash flares in atopic dermatitis, contact dermatitis, and autoimmune progesterone dermatitis. Join our fun, banter-filled discussion to stay ahead in dermatology!In This Episode:Stage 3A Melanoma: Is adjuvant therapy worth it, and what’s the best option?Dermatomyositis: Consequences of misdiagnosis and delayed diagnosisVitiligo: Could hydroxychloroquine be a game-changer over NBUVB?Skin Inflammation: A key driver of food allergyPemphigoid: Insights into immunotherapy-induced casesPremenstrual Rashes: Managing flares in atopic1. Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.2. Patterns and Clinical Implications of Misdiagnosis in Dermatomyositis3. Effectiveness, Tolerability and Safety of Topical Clobetasol with Oral Hydroxychloroquine versus Topical Clobetasol with NBUVB Phototherapy in Unstable Vitiligo: Investigator Blind, Randomized Controlled Trial4. Skin damage signals mediate allergic sensitization to spatially unlinked antigen5. Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid6. The impact of the menstrual cycle on exacerbations of atopic dermatitis: a systematic review7. Nickel contact allergy and menstrual cycle8. Autoimmune progesterone dermatitis: Update and insightsDerms on Drugs is produced by Scholars in Medicine.com
--------
52:01
Radiation Therapy for Skin Cancer - Dermatology Office Appropriate or Too Hot to Handle?
Should dermatologists offer Image Guided Superficial Radiation Therapy (IGSRT) in-office or refer radiation oncologists when radiation is appropriate? Join Derms on Drugs as we tackle this "burning" question with two expert radiation oncologists. While dermatologists are THE skin cancer experts, radiation therapy isn't our usual domain— so is IGSRT a game-changer for your practice or too far outside our realm? Explore clinical insights, practical considerations, and the latest evidence to guide your decision-making. Perfect for dermatologists, PAs, NPs, residents, medical students, and pharma professionals in dermatology seeking to stay ahead of the curve. Tune in to discover if IGSRT could light up your approach to patient care—or leave you glowing in the dark.#Dermatology #SkinCancer #IGSRT #RadiationTherapy #DermEducation1. Updated results of 3,050 non-melanoma skin cancer (NMSC) lesions in 1725 patients treated with high resolution dermal ultrasoundguided superficial radiotherapy, a multiinstitutional study ScholarsInMedicine.com2. The Role of Image-Guided Superficial Radiation Therapy in the Treatment of Nonmelanoma Skin Cancer3. Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study
--------
53:53
SCC Scares, Lichen Planus Cancer Risks, CSU Breakthroughs, Psoriasis Wins, Chemo Hacks, and HS Itch Relief
Buckle up for a whirlwind tour of the hottest dermatology literature. This week, we’ve got the deets on:Cutaneous squamous cell carcinoma: What predicts when it'll go rogue and metastasize? Spoiler: It’s not just bad vibes.Oral lichen planus: Turns out, its cancer risk is sneakier than a derm resident dodging clinic.Remibrutinib for CSU: The first oral game-changer for chronic spontaneous urticaria. Hives, meet your match!Psoriasis biologics: Which systemic treatments keep infections at bay? We’ve got the lowdown.Chemo’s conundrum: One bizarre trick to stop a cutaneous side effectsHidradenitis suppurativa itch: Dermeleve’s here to make HS patients stop scratching and start living.Join us for laughs, learning, and maybe a few gasps as we unpack the science that’s got the derm world buzzing. Perfect for dermatologists, PAs, NPs, pharma folks, and students who live for skin-deep insights. Subscribe, share, and let’s make dermatology lit! #DermatologyPodcast #DermLifeScholarsinMedicine.com
Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology.
It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful.
Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.
Ireland